HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamashita, G. Articles by Holzbach, R. T. Search for Related Content PubMed PubMed Citation Articles by Yamashita, G. Articles by Holzbach, R. T. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 1325-1333, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

Biliary haptoglobin, a potent promoter of cholesterol crystallization at physiological concentrations

G Yamashita, SG Corradini, R Secknus, A Takabayashi, C Williams, L Hays, AL Chernosky and RT Holzbach
Gastrointestinal Research Unit, Cleveland Clinic Foundation, OH 44195- 5218, USA.

BACKGROUND/AIMS: Several proteins present in human bile have been reported to promote cholesterol crystallization and thus are potentially important in the formation of cholesterol crystals as the initial stage in gallstone pathogenesis. To be physiologically relevant, such proteins must either be present in high concentration in bile or have a potent promoting activity. The current study explored several of the more abundant but unexamined biliary proteins based upon their also having sufficiently high serum concentrations that antibodies were available for both their isolation and quantitation. METHODS: Protein purification was accomplished by immunoaffinity chromatography of bile followed by delipidation. Con A affinity chromatography of bile was used to obtain the bound fraction, a portion of which was delipidated. Crystallization-promoting activity of both the purified proteins and Con A-bound glycoprotein fractions (CABG) was measured by a photometric crystal growth assay. A competitive antibody- capture ELISA assay was developed to measure concentrations of alpha 1- antitrypsin, transferrin, and haptoglobin in native bile. RESULTS: At their relevant physiological concentrations, biliary haptoglobin (15 micrograms/ml) had a crystallization-promoting activity twice that of the biliary IgM (75 micrograms/ml) used as a reference standard (P < 0.05). Biliary transferrin (20 micrograms/ml) had only modest promoting activity (P < 0.05). Biliary alpha 1-antitrypsin (50 micrograms/ml), by contrast, showed no promoting activity. Delipidation of the CABG fraction decreased its promoting activity by 75%. Biliary haptoglobin accounts for about 30% of delipidated total CABG-promoting activity. CONCLUSIONS: Biliary haptoglobin at its physiological concentration has a highly potent crystallization-promoting activity and thus becomes a candidate for major attention in understanding gallstone pathogenesis.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Nakagawa, N. Uozumi, M. Nakano, Y. Mizuno-Horikawa, N. Okuyama, T. Taguchi, J. Gu, A. Kondo, N. Taniguchi, and E. Miyoshi Fucosylation of N-Glycans Regulates the Secretion of Hepatic Glycoproteins into Bile Ducts J. Biol. Chem., October 6, 2006; 281(40): 29797 - 29806. [Abstract] [Full Text] [PDF]

				P. Portincasa, N. G. Venneman, A. Moschetta, A. van den Berg, G. Palasciano, G. P. vanBerge-Henegouwen, and K. J. van Erpecum Quantitation of cholesterol crystallization from supersaturated model bile J. Lipid Res., April 1, 2002; 43(4): 604 - 610. [Abstract] [Full Text] [PDF]

				E. Fosslien Mitochondrial Medicine - Molecular Pathology of Defective Oxidative Phosphorylation Ann. Clin. Lab. Sci., January 1, 2001; 31(1): 25 - 67. [Abstract] [Full Text] [PDF]

				D. Q-H. Wang, D. E. Cohen, F. Lammert, and M. C. Carey No pathophysiologic relationship of soluble biliary proteins to cholesterol crystallization in human bile J. Lipid Res., March 1, 1999; 40(3): 415 - 425. [Abstract] [Full Text]